Methods
This study is an investigator-initiated, phase II, single-armed trial in a single institution. It was approved by the Medical Ethical Committee of Shandong University Qilu Hospital (Number: 2018214) and was conducted in accordance with the Declaration of Helsinki. This clinical trial was registered at 